Emile, Sameh Hany
Horesh, Nir
Garoufalia, Zoe
Rogers, Peter
Gefen, Rachel
Dasilva, Giovanna
Wexner, Steven D. https://orcid.org/0000-0001-8046-5753
Article History
Received: 18 August 2023
Accepted: 23 September 2023
First Online: 9 October 2023
Declarations
:
: None of the authors reports any relevant financial disclosures. Dr. Wexner reports receiving consulting fees from ARC/Corvus, Astellas, Baxter, Becton Dickinson, GI Supply, ICON Language Services, Intuitive Surgical, Leading BioSciences, Livsmed, Medtronic, Olympus Surgical, Stryker, Takeda and receiving royalties from Intuitive Surgical and Karl Storz Endoscopy America Inc. Dr. Emile reports receiving consulting fees from SafeHeal.
: A prospectively maintained IRB-approved database of patients with rectal cancer was used for the study.
: For this type of study, formal consent is not required